Literature DB >> 17397827

Adenoviral-mediated expression of dihydropyridine-insensitive L-type calcium channels in cardiac ventricular myocytes and fibroblasts.

Kenneth B Walsh1, Jining Zhang, John W Fuseler, Nathan Hilliard, Gregory H Hockerman.   

Abstract

Cardiac voltage-gated Ca2+ channels regulate the intracellular Ca2+ concentration and are therefore essential for muscle contraction, second messenger activation, gene expression and electrical signaling. As a first step in accessing the structural versus functional properties of the L-type Ca2+ channel in the heart, we have expressed a dihydropyridine (DHP)-insensitive CaV1.2 channel in rat ventricular myocytes and fibroblasts. Following isolation and culture, cells were infected with adenovirus expressing either LacZ or a mutant CaV1.2 channel (CaV1.2DHPi) containing the double mutation (T1039Y & Q1043M). This mutation renders the channel insensitive to neutral DHP compounds such as nisoldipine. The whole-cell, L-type Ca2+ current (ICa) measured in control myocytes was inhibited in a concentration-dependent manner by nisoldipine with an IC50 of 66 nM and complete block at 250 nM. In contrast, ICa in cells infected with AdCaV1.2DHPi was inhibited by only 35% by 500 nM nisoldipine but completely blocked by 50 microM diltiazem. In order to study CaV1.2DHPi in isolation, myocytes infected with AdCaV1.2DHPi were incubated with nisoldipine. Under this condition the cells expressed a large ICa (12 pA/pF) and displayed Ca2+ transients during field stimulation. Furthermore, addition of 2 microM forskolin and 100 microM 3-isobutyl-1-methylxanthine (IBMX), to stimulate protein kinase A, strongly increased IBa in the AdCaV1.2DHPi-infected cells. A Cd2+-sensitive IBa was also recorded in cardiac fibroblasts infected with AdCaV1.2DHPi. Thus, expression of CaV1.2DHPi will provide an important tool in studies of cardiac myocyte and fibroblast function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17397827     DOI: 10.1016/j.ejphar.2007.02.049

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Manipulating L-type calcium channels in cardiomyocytes using split-intein protein transsplicing.

Authors:  Prakash Subramanyam; Donald D Chang; Kun Fang; Wenjun Xie; Andrew R Marks; Henry M Colecraft
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-03       Impact factor: 11.205

2.  Distinct properties of amlodipine and nicardipine block of the voltage-dependent Ca2+ channels Cav1.2 and Cav2.1 and the mutant channels Cav1.2/dihydropyridine insensitive and Cav2.1/dihydropyridine sensitive.

Authors:  Min Lin; Oluyemi Aladejebi; Gregory H Hockerman
Journal:  Eur J Pharmacol       Date:  2011-09-02       Impact factor: 4.432

3.  Functional expression of transgenic 1sDHPR channels in adult mammalian skeletal muscle fibres.

Authors:  Marino DiFranco; Philip Tran; Marbella Quiñonez; Julio L Vergara
Journal:  J Physiol       Date:  2011-01-24       Impact factor: 5.182

4.  Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation.

Authors:  Thomas O'Hara; László Virág; András Varró; Yoram Rudy
Journal:  PLoS Comput Biol       Date:  2011-05-26       Impact factor: 4.475

5.  Simulation of the Effects of Extracellular Calcium Changes Leads to a Novel Computational Model of Human Ventricular Action Potential With a Revised Calcium Handling.

Authors:  Chiara Bartolucci; Elisa Passini; Jari Hyttinen; Michelangelo Paci; Stefano Severi
Journal:  Front Physiol       Date:  2020-04-15       Impact factor: 4.566

6.  Nifedipine Inhibition of High-Voltage Activated Calcium Channel Currents in Cerebral Artery Myocytes Is Influenced by Extracellular Divalent Cations.

Authors:  Fei Wang; Masayo Koide; George C Wellman
Journal:  Front Physiol       Date:  2017-04-07       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.